Radiology Registry on Pancreatic Malignancies
- Pancreatic Cancer
- Pancreas Neoplasm
- Pancreas Disease
- Pancreas Cyst
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- IRCCS San Raffaele
- Enrolment target
- 1,300
- Started
- 4 March 2022
- Main results due
- 30 March 2027
- Study sites
- 1
- Registry updated
- 23 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * ≥18 years of age * Patients with suspect (planned for investigation) or diagnosed pancreatic cancer at any stage. * able and willing to sign informed consent Exclusion Criteria: * Patients with non-primary pancreatic disease
What this study is about
In the sponsor’s own words, from the registry.
The purpose of this study is to collect all radiological data which evaluated with clinical data may help assess malignancy and prognosis of pancreatic disease.This registry aims to collect retrospective data from 2014 and prospective data until 2027 with a maximum follow-up of 3 years per patient.
Study sites(1)
Department of Radiology, IRCCS Ospedale San Raffaele
Milan, Italy
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT05714111. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me